Atea Pharmaceuticals Stock Analysis

Atea Stock Analysis Notes

About 14.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.1. Some equities with similar Price to Book (P/B) outperform the market in the long run. Atea Pharmaceuticals recorded a loss per share of 1.77. The entity last dividend was issued on the 9th of November 2012. The firm had 1:6 split on the 9th of November 2012. Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts. Atea Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 63 people. For more info on Atea Pharmaceuticals please contact the company at 857 284 8891 or go to https://ateapharma.com.

Atea Pharmaceuticals Investment Alerts

Atea Largest EPS Surprises

View All Earnings Estimates

Atea Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Atea Stock Institutional Investors

Note, although Atea Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Atea Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 348.45 M.

Atea Profitablity

Management Efficiency

Atea Pharmaceuticals has return on total asset (ROA) of (0.2386) % which means that it has lost $0.2386 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3798) %, meaning that it created substantial loss on money invested by shareholders. Atea Pharmaceuticals' management efficiency ratios could be used to measure how well Atea Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/13/2026, Return On Tangible Assets is likely to drop to -0.34. In addition to that, Return On Capital Employed is likely to drop to -0.41. At this time, Atea Pharmaceuticals' Total Assets are relatively stable compared to the past year. As of 02/13/2026, Total Current Assets is likely to grow to about 535.3 M, while Net Tangible Assets are likely to drop slightly above 398.8 M.

Technical Drivers

As of the 13th of February 2026, Atea Pharmaceuticals shows the risk adjusted performance of 0.1186, and Mean Deviation of 2.44. Atea Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Atea Pharmaceuticals standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if Atea Pharmaceuticals is priced correctly, providing market reflects its regular price of 4.33 per share. Given that Atea Pharmaceuticals has jensen alpha of 0.424, we suggest you to validate Atea Pharmaceuticals's prevailing market performance to make sure the company can sustain itself at a future point.

Atea Pharmaceuticals Price Movement Analysis

Atea Pharmaceuticals Insider Trading Activities

Atea Pharmaceuticals Outstanding Bonds

Atea Pharmaceuticals Predictive Daily Indicators

Atea Pharmaceuticals Forecast Models

Atea Pharmaceuticals' time-series forecasting models are one of many Atea Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Atea Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Atea Pharmaceuticals Bond Ratings

Atea Pharmaceuticals financial ratings play a critical role in determining how much Atea Pharmaceuticals have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Atea Pharmaceuticals' borrowing costs.

Atea Pharmaceuticals Debt to Cash Allocation

Atea Pharmaceuticals currently holds 1.64 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Atea Pharmaceuticals has a current ratio of 26.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Atea Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.

Atea Pharmaceuticals Total Assets Over Time

Atea Pharmaceuticals Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Atea Pharmaceuticals uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Atea Pharmaceuticals Debt Ratio

0.25

It seems most of the Atea Pharmaceuticals' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Atea Pharmaceuticals' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Atea Pharmaceuticals, which in turn will lower the firm's financial flexibility.

Atea Pharmaceuticals Corporate Bonds Issued

Atea Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how Atea Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Atea shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Atea Pharmaceuticals. By using and applying Atea Stock analysis, traders can create a robust methodology for identifying Atea entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Atea analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Atea analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Atea Pharmaceuticals stock analysis indicators help investors evaluate how Atea Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Atea Pharmaceuticals shares will generate the highest return on investment. By understating and applying Atea Pharmaceuticals stock analysis, traders can identify Atea Pharmaceuticals position entry and exit signals to maximize returns.

When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.